Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Annual Review of Medicine|March 12, 1999
Hereditary peripheral neuropathies: clinical forms, genetics, and molecular mechanismsL E Warner, C A Garcia, J R LupskiHuman Molecular Genetics|June 17, 1999
Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathiesL E Warner, J Svaren, J Milbrandt, et al.Human Mutation|January 1, 1997
Multiple de novo MPZ (P0) point mutations in a sporadic Dejerine-Sottas caseL E Warner, M Shohat, Z Shorer, et al.Pediatric Neurology|April 20, 1999
Congenital hypomyelinating neuropathy: two patients with long-term follow-upJ P Phillips, L E Warner, J R Lupski, et al.Annals of the New York Academy of Sciences|November 1, 2017
Molecular Mechanisms for CMT1A Duplication and HNPP DeletionC F Boerkoel, K Inoue, L T Reiter, et al.Annals of the New York Academy of Sciences|December 10, 1999
Molecular mechanisms for CMT1A duplication and HNPP deletionC F Boerkoel, K Inoue, L T Reiter, et al.European Journal of Human Genetics : EJHG|January 1, 1996
Comparison of single-strand conformation polymorphism and heteroduplex analysis for detection of mutations in Charcot-Marie-Tooth type 1 disease and related peripheral neuropathiesE Nelis, L E Warner, E D Vriendt, et al.Nature Genetics|April 16, 1998
Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathiesL E Warner, P Mancias, I J Butler, et al.Muscle & Nerve|January 20, 2000
Unusual electrophysiological findings in X-linked dominant Charcot-Marie-Tooth diseaseA Gutierrez, J D England, A J Sumner, et al.Human Mutation|January 1, 1996
Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth diseaseB B Roa, L E Warner, C A Garcia, et al.Pageof 2